Health News Roundup: Coronavirus cases in S. Korea; NZ moves to ban vaping ads and moreDevdiscourse News Desk | Updated: 23-02-2020 10:37 IST | Created: 23-02-2020 10:31 IST
Following is a summary of current health news briefs.
China's Hubei province revises February 19 new cases tally to 775, from 349 previously
China's Hubei province, the epicentre of the coronavirus outbreak, on Friday revised the number of new cases it reported on Feb. 19 to 775, from 349 previously. Earlier in the day, provincial authorities said they would add back some cases to their tally of the disease, after they adjusted their methodology to count only cases that were detected with genetic tests, rather than with CT scans.
World must act fast to contain coronavirus: WHO's Tedros
The window of opportunity to contain wider international spread of the epidemic of the new coronavirus disease is closing, the World Health Organization (WHO) warned on Friday, after cases were reported in Iran and Lebanon. Tedros Adhanom Ghebreyesus, WHO director-general, asked whether the outbreak is at a "tipping point" after new cases and deaths in Iran from COVID-19, and cases in Lebanon and Canada, said that he still believed the virus spread could be stopped.
Sealed in: Chinese trapped at home by coronavirus feel the strain
During weeks holed up in her grandmother's apartment with 10 relatives and eating a restricted diet, Chinese teenager Li Yuxuan says tempers have frayed. Li and her family are among the millions of people across China's Hubei province, epicenter of the coronavirus outbreak, who are subject to official orders to stay at home amid attempts to contain the spread of the disease.
Japan govt faces questions over coronavirus, Tokyo cancels events
Japan faced growing questions about whether it was doing enough to stop the spread of the coronavirus on Friday, as the Tokyo Metropolitan Government said it would cancel or postpone major indoor events it has sponsored for the next three weeks. More than 400 Japanese and foreign passengers were set to disembark from the virus-hit Diamond Princess cruise ship near Tokyo after weeks aboard in quarantine, despite reports of new cases coming in from around Japan.
U.S. prepares for coronavirus pandemic, school and business closures: health officials
U.S. health officials on Friday said they are preparing for the possibility of the spread of the new coronavirus through U.S. communities that would force closures of schools and businesses. The United States has yet to see community spread of the virus that emerged in central China in late December. But health authorities are preparing medical personnel for the risk, Nancy Messonnier, an official with the Centers for Disease Control and Prevention (CDC) told reporters on a conference call.
China reports fewer coronavirus cases outside epicenter, cases surge in South Korea
China reported another fall in the new coronavirus infections outside of its epicenter on Sunday, but world health officials warned it was too early to make predictions about the outbreak as new infections and fears of contagion increased elsewhere. China's health commission confirmed 648 new infections on Sunday - higher than a day earlier - but only 18 were outside of Hubei province, the lowest number outside of the epicenter since authorities started publishing data a month ago.
New Zealand moves to ban vaping ads, sales to minors
New Zealand's government said on Sunday it will introduce laws banning all advertisements of e-cigarettes and the sale of such products to people under 18 in a move to regulate a market that has been under pressure globally. A string of vaping-related deaths and illnesses tied to e-cigarettes, which allow users to inhale nicotine vapor, often flavored, without smoking, have been reported in the United States, leading to lawsuits and restrictions.
FDA approves Lundbeck's migraine prevention therapy
The U.S. Food and Drug Administration approved Lundbeck A/S' migraine prevention therapy, which the Danish drugmaker acquired through its near $2 billion deal for Alder BioPharmaceuticals in 2019, the company said on Friday. For Lundbeck, the approval opens doors to a lucrative but competitive market dominated by already approved rivals from Amgen Inc, Teva Pharmaceutical Industries Ltd and Eli Lilly and Co.
Esperion says cholesterol drug gets U.S. approval; eyes $10 per pill pricing
Esperion Therapeutics Inc said on Friday that U.S. health regulators approved its cholesterol-lowering drug, making it the first non-statin treatment to be cleared for sale in the country in nearly 20 years. The drug, bempedoic acid, to be used as an add-on treatment with statins, lowers bad cholesterol or low-density lipoprotein (LDL) by inhibiting its synthesis in the liver and is aimed at patients with high cardiovascular risk, the company said in a statement.
FDA approves Eli Lilly's Trulicity to reduce cardiovascular risks in type 2 diabetic patients
Eli Lilly and Co said on Friday the U.S. Food and Drug Administration has approved Trulicity for reducing cardiovascular risk factors in type 2 diabetic patients. The approval makes Trulicity the first and only type 2 diabetes drug approved to reduce heart related risks in adults with and without established cardiovascular disease, the company said in a statement.
(With inputs from agencies.)
Download The Devdiscourse News App for Latest News.